Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03741322 · ClinicalTrials.gov registry record
A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness
A clinical trial of Respiratory Tract Infections and Wheezing, sponsored by Duke University.
- Completed
- Registry status
- 5
- Enrollment target
- 1
- Study location
NCT03741322: Completed study of Respiratory Tract Infections and Wheezing, sponsored by Duke University.
NCT03741322 is a study of Respiratory Tract Infections and Wheezing that has completed, run by Duke University. The registered enrollment target is 5 participants, below the 2,774-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03741322, a study of Respiratory Tract Infections and Wheezing, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will identify infants between the age of 3 and 24 months of age who are experiencing one of their first acute respiratory infections with confirmed wheezing. Infants who are also confirmed to be wheezing and whose caregiver signs consent will be enrolled from a primary care clinic, emergency room or hospital.
Primary Outcome
Participants will be assessed for meeting criteria for the persistent asthma phenotype which will be defined as meeting any Asthma Predicative Indices plus abnormal lung pulmonary function testing by Impulse oscillometry (either from peripheral airway resistance or bronchodilator responsiveness).
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-12-12 |
| Est. Completion | 2020-06-16 |
What the finished NCT03741322 record still lists
NCT03741322 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 2,774-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Respiratory Tract Infections appearing as the primary indexed condition, and to 0 interventions.
NCT03741322 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03741322 about?
NCT03741322 is a clinical study titled "A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness". This study will identify infants between the age of 3 and 24 months of age who are experiencing one of their first acute respiratory infections with confirmed wheezing. Infants who are also confirmed to be wheezing and whose caregiver signs consent will be enrolled from a primary care clinic, emerge...
What is the current status of trial NCT03741322?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2018-12-12. Estimated completion is 2020-06-16.
What conditions does trial NCT03741322 study?
This clinical trial studies the following conditions: Respiratory Tract Infections, Wheezing.
Who is sponsoring clinical trial NCT03741322?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03741322 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03741322's enrollment target sits among peer trials
5 16th of 15 the lowest of 15 other Respiratory Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
RECRUITING · NA
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
RECRUITING · NA
-
Beetroot Juice NO Cold Study
RECRUITING · Phase 2
-
Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI